Pacira BioSciences Inc. (PCRX)
NASDAQ: PCRX
· Real-Time Price · USD
24.51
0.28 (1.16%)
At close: Jun 23, 2025, 11:38 AM
1.16% (1D)
| Bid | 24.5 |
| Market Cap | 1.13B |
| Revenue (ttm) | 702.77M |
| Net Income (ttm) | -103.73M |
| EPS (ttm) | -2.24 |
| PE Ratio (ttm) | -10.94 |
| Forward PE | 7.04 |
| Analyst | Buy |
| Ask | 24.52 |
| Volume | 76,249 |
| Avg. Volume (20D) | 853,235 |
| Open | 24.36 |
| Previous Close | 24.23 |
| Day's Range | 24.29 - 24.56 |
| 52-Week Range | 11.16 - 29.61 |
| Beta | 0.51 |
About PCRX
undefined
Industry n/a
Sector n/a
IPO Date n/a
Employees NaN
Stock Exchange n/a
Ticker Symbol PCRX
Website n/a
Analyst Forecast
According to 0 analyst ratings, the average rating for PCRX stock is "n/a." The 12-month stock price forecast is $n/a, which is a decrease of 0% from the latest price.
Stock ForecastsNext Earnings Release
Pacira BioSciences Inc. is scheduled to release its earnings on Jul 29, 2025,
during market hours.
Analysts project revenue of ... Unlock content with Pro Subscription
Analysts project revenue of ... Unlock content with Pro Subscription
2 months ago
+14.67%
Pacira BioSciences shares are trading higher after...
Unlock content with
Pro Subscription
2 months ago
-0.82%
Pacira BioSciences shares are trading higher after the company announced settlement of litigation related to EXPAREL patents.
